SEC Declares Form S-4 Registration Statement “Effective” for Proposed Business Combination of Larkspur Health Acquisition Corp., Inc. with ZyVersa Therapeutics, Inc.
- Tuesday, November 15, 2022, 7:14
- Environment
- Add a comment
Special meeting of Larkspur stockholders scheduled for December 8, 2022, to vote on the proposed business combination of Larkspur with ZyVersa ZyVersa is a clinical stage biopharmaceutical company with two licensed proprietary product platforms, a cholesterol efflux mediator targeting…
About the Author
adminasapcorp has written 41828 stories on this site.